drugset / Trial / NCT03013790

Melatonin Use in the Intensive Care Elderly Population

NCT03013790

Phase 4 Unknown 600 enrolled MICE Trial Group
RandomizedParallel-groupDouble-blindPrevention

Summary

The investigators are studying the use of Melatonin in non-ventilated patients over the age of 65. Primary endpoint will be assesments of delirium, with secondary endpoints to include length of stay, use of anti-psychotic medications, and mortality

Timeline

Start
2016-12
Primary completion
2018-01
Completion
2018-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Melatonin Small molecule 3 mg Oral
Comparator Melatonin Small molecule 5 mg Oral

Indications